What is the current Price Target for the Evaxion Biotech A/S - ADR stock?

The average Evaxion Biotech A/S - ADR target price is $10.20. This is 249.32% higher than the current stock price. The highest price target is 403.42%, the lowest is 107.53%. 4 Analysts have issued a price target Evaxion Biotech A/S - ADR 2026 .

How high will the Evaxion Biotech A/S - ADR stock rise?

No reliable answer can be given as to how high the Evaxion Biotech A/S - ADR stock will rise. The performance of stocks, including the Evaxion Biotech A/S - ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Evaxion Biotech A/S - ADR stock today?

The performance of Evaxion Biotech A/S - ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Evaxion Biotech A/S - ADR stock fall?

The decline in Evaxion Biotech A/S - ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Evaxion Biotech A/S - ADR Forecast, price target & analysts

$2.92

8.35%

Nasdaq, Sep 05, 10:00 pm CET

ISIN

US29970R1059

Symbol

EVAX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Evaxion Biotech A/S - ADR Target price 2025 - Analyst rating & recommendation

Evaxion Biotech A/S - ADR Classifications & Recommendation:

Buy

88%

Hold

13%

Evaxion Biotech A/S - ADR Price Target

Target Price	$10.20
Price	$2.92
Potential	249.32% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Evaxion Biotech A/S - ADR 2026 . The average Evaxion Biotech A/S - ADR target price is $10.20. This is 249.32% register free of charge higher than the current stock price. The highest price target is $14.70 403.42% register free of charge , the lowest is $6.06 107.53% register free of charge .
	A rating was issued by 8 analysts: 7 Analysts recommend Evaxion Biotech A/S - ADR to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Evaxion Biotech A/S - ADR stock has an average upside potential 2026 of 249.32% register free of charge . Most analysts recommend the Evaxion Biotech A/S - ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.98	-2.27
	97.58%	131.63%
P/E		negative

4 Analysts have issued a Evaxion Biotech A/S - ADR forecast for earnings per share. The average Evaxion Biotech A/S - ADR EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-0.98	97.58%
2025	$-2.27 131.63% Unlock
2026	$-1.92 15.42% Unlock
2027	$0.05 102.60% Unlock
2028	$0.05 0.00% Unlock
2029	$0.10 100.00% Unlock
2030	$-0.02 120.00% Unlock
2031	$0.02 200.00% Unlock
2032	$0.08 300.00% Unlock

Current	-97.33	799.93%
2025	-1.29 98.67% Unlock
2026	-1.52 17.83% Unlock
2027	57.25 3,866.45% Unlock
2028	57.25 0.00% Unlock
2029	28.63 49.99% Unlock
2030	-143.14 599.97% Unlock
2031	143.14 200.00% Unlock
2032	35.78 75.00% Unlock

Evaxion Biotech A/S - ADR...

Current Evaxion Biotech A/S - ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Apr 02 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 20 2025
Lake Street	Locked ➜ Locked	Locked	Feb 04 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 03 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 01 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 26 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 20 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Apr 02 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 20 2025
Locked Lake Street: Locked ➜ Locked	Feb 04 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 03 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 01 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 26 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 20 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 27.90%

BioNTech SE - ADR 23.80%

Deutsche Telekom 22.46%

Rheinmetall 22.26%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now